Ulnar Osteochondritis Dissecans (Ulnar OCD)

Overview

Osteochondritis dissecans (OCD) of the ulna is a joint condition in which a fragment of bone and its overlying cartilage lose their normal blood supply, become unstable, and may eventually separate from the surrounding bone. While OCD is most commonly described at the knee, elbow, and ankle, involvement of the ulna—especially the distal (near the wrist) or proximal (near the elbow) epiphysis—is relatively rare.

Who it affects: The condition typically occurs in adolescents and young adults, with a peak incidence between ages 12‑18. Males are affected roughly 2‑3 times more often than females.^[1][2] Most cases are unilateral, but bilateral involvement has been reported.

Prevalence: Precise population‑wide numbers are lacking because ulnar OCD is uncommon. In a review of 1,200 elbow OCD cases, only 4‑5 % involved the ulna.^[3] Among athletes, especially those in overhead or throwing sports, the prevalence rises to roughly 0.05 %–0.1 % of participants.^[4]

Symptoms

Symptoms may develop gradually or after a specific injury. The most frequent complaints include:

• Pain: Deep, aching pain localized over the ulnar side of the joint. Pain is often worse with activity (throwing, gripping) and may improve with rest.
• Mechanical symptoms: A sense of catching, clicking, or locking when the elbow or wrist moves.
• Swelling: Mild to moderate joint effusion, especially after exertion.
• Stiffness: Decreased range of motion, particularly in extension (elbow) or ulnar deviation (wrist).
• Weakness: Grip strength may diminish due to pain or joint incongruity.
• Visible deformity: In advanced cases, a palpable “loose body” may be felt under the skin.
• Pain at night: Persistent night pain that disturbs sleep is a red‑flag for lesion instability.

Causes and Risk Factors

Underlying Pathophysiology

OCD is thought to result from a combination of vascular insufficiency and repetitive micro‑trauma to the growth plate (physis). The immature bone receives less blood flow, making it vulnerable to ischemic necrosis. Over time, the necrotic area may separate from surrounding bone, creating a loose osteochondral fragment.

Risk Factors

• Age & growth plate status: Active growth plates (typically before skeletal maturity) increase susceptibility.
• Gender: Males are at higher risk.
• Sports participation: Overhead throwing (baseball, softball), gymnastics, tennis, and wrestling place repetitive stress on the ulna.
• Repetitive loading: Activities that involve sudden elbow or wrist valgus/varus forces.
• Previous trauma: A single impact or a series of minor injuries can precipitate lesion formation.
• Genetic predisposition: Family history of OCD or other osteochondral disorders may raise risk, though data are limited.
• Hormonal/endocrine factors: Conditions that affect bone turnover (e.g., adolescent growth spurts, endocrine disorders) may contribute.

Diagnosis

Diagnosis combines a thorough history, physical examination, and imaging studies.

Clinical Examination

• Localized tenderness over the ulnar side of the joint.
• Pain reproduction with resisted forearm pronation/supination (elbow) or ulnar deviation (wrist).
• Assessment of joint stability and range of motion.

Imaging Studies

1. Plain Radiographs (X‑ray): First‑line. Anteroposterior (AP) and lateral views may reveal a radiolucent “defect” with surrounding sclerosis. In later stages, a loose body may be visible.
2. Magnetic Resonance Imaging (MRI): Gold standard for lesion staging. MRI shows:
   • Extent of subchondral bone involvement.
   • Stability of the fragment (fluid signal between fragment and bone indicates instability).
   • Associated cartilage damage.
3. Computed Tomography (CT): Useful for detailed bone anatomy, especially pre‑operative planning.
4. Arthroscopy: Direct visualization and the ability to treat the lesion in the same setting; reserved for cases where non‑invasive imaging is inconclusive.

Classification Systems

The Hefti and Nelson classifications, originally created for knee OCD, have been adapted for the elbow/wrist. They grade lesions from stable (intact cartilage, no fluid gap) to unstable (loose fragment, detached cartilage).

Treatment Options

Management depends on lesion stability, patient age, skeletal maturity, and functional demands. Goals are to relieve pain, restore joint congruity, and prevent degeneration.

Non‑Surgical (Conservative) Treatment

• Activity Modification: Stop or limit activities that provoke pain (throwing, heavy lifting). Usually recommended for 6‑12 weeks.
• Immobilization: A removable splint or brace in a functional position (e.g., 20‑30° flexion for elbow) for 4‑6 weeks can promote healing in stable lesions.
• Physical Therapy: Progressive range‑of‑motion and strengthening program focusing on scapular stabilizers, rotator cuff, forearm flexors/extensors, and grip strength.
• Pharmacologic Pain Control: Acetaminophen or NSAIDs (ibuprofen, naproxen) as needed. Use caution with prolonged NSAID use in adolescents.
• Biological Adjuncts (experimental): Autologous platelet‑rich plasma (PRP) injections have shown modest benefit in small case series, but robust evidence is lacking.^[5]

Conservative treatment is most successful in skeletally immature patients with stable lesions—healing rates of 70‑85 % have been reported.^[6]

Surgical Options

Surgery is indicated for unstable lesions, failed conservative care after 3‑4 months, or lesions in skeletally mature individuals.

1. Arthroscopic Debridement & Microfracture:
   • Removal of loose cartilage and creation of micro‑fractures in subchondral bone to stimulate fibrocartilage repair.
   • Best for lesions < 2 cm².
2. Fragment Fixation:
   • Internal fixation using bioabsorbable pins, screws, or headless compression screws to preserve the native osteochondral piece.
   • Ideal when fragment is viable and congruent.
3. Osteochondral Autograft Transfer (OAT) / Mosaicplasty:
   • Harvesting cylindrical osteochondral plugs from a non‑weight‑bearing area (often distal radius) and implanting them into the defect.
   • Provides hyaline cartilage resurfacing.
4. Autologous Chondrocyte Implantation (ACI):
   • Two‑stage procedure: cartilage cells are harvested, cultured, and later injected under a peri‑periosteal flap.
   • Reserved for larger lesions (>2 cm²) in adults.
5. Ulnar Osteotomy:
   • Realignment of the ulna to off‑load the affected area, occasionally combined with cartilage restoration techniques.

Post‑operative protocols usually involve a brief period of immobilization (1‑2 weeks), followed by gradual range of motion and strengthening. Full return to high‑impact sports typically takes 4‑6 months, depending on the procedure.

Medication Summary

Medication	Purpose	Typical Dose (adults)
Ibuprofen	Pain & inflammation	400‑600 mg PO q6‑8h
Naproxen	Pain & inflammation	250‑500 mg PO BID
Acetaminophen	Analgesia	500‑1000 mg PO q6h (max 3 g/day)
Opioids (short‑term)	Severe pain	Hydrocodone 5‑10 mg PO q6‑8h PRN

Living with Ulnar Osteochondritis Dissecans

Even after successful treatment, patients may need to adopt lifestyle habits that protect the joint and maintain function.

Daily Management Tips

• Warm‑up & Stretching: Perform dynamic warm‑ups (arm circles, wrist flexor/extensor stretches) before activity.
• Strengthening: Incorporate forearm pronation/supination, grip exercises, and scapular stabilizer work 3‑4 times per week.
• Activity Pacing: Use the “10‑minute rule”—if pain worsens after 10 minutes of continuous activity, pause and rest.
• Ergonomic Adjustments: For desk work, keep the forearm neutral and use wrist supports if needed.
• Protective Gear: In contact sports, wear elbow or wrist pads to dampen impact.
• Regular Follow‑up: Imaging (X‑ray or MRI) every 6‑12 months for the first two years post‑treatment to monitor healing.
• Nutrition: Adequate calcium (1,000–1,300 mg/day) and vitamin D (600–800 IU/day) support bone health.

Return‑to‑Sport Guidelines

1. Phase 1 (0‑2 weeks): Immobilization & pain control.
2. Phase 2 (2‑6 weeks): Gentle range of motion, isometric forearm exercises.
3. Phase 3 (6‑12 weeks): Progressive resistance training; no throwing or heavy lifting.
4. Phase 4 (3‑4 months): Sport‑specific drills, gradual increase in intensity.
5. Phase 5 (6 months+): Full competition, provided pain‑free ROM and strength ≥90 % of the unaffected side.

Prevention

Because a component of ulnar OCD is repetitive micro‑trauma, preventive strategies focus on load management and joint conditioning.

• Limit Overuse: Follow age‑appropriate guidelines for pitch counts in baseball (e.g., MLB Pitch‑Count Recommendations).
• Balanced Training: Combine strength, flexibility, and proprioception work to distribute forces evenly across the joint.
• Early Symptom Recognition: Teach young athletes to report joint pain early rather than “playing through” it.
• Proper Technique: Coaching on correct throwing mechanics and wrist positioning reduces abnormal shear forces.
• Cross‑Training: Alternate high‑impact activities with low‑impact options (swimming, cycling) to give the ulna time to recover.

Complications

If left untreated or inadequately managed, ulnar OCD can lead to:

• Joint Degeneration: Early onset osteoarthritis of the elbow or wrist.
• Loose Body Formation: Migrating fragments can cause mechanical blockage, locking, or cartilage wear.
• Growth Disturbance: In skeletally immature patients, physeal damage may result in limb length discrepancy or angular deformity.
• Chronic Pain & Functional Limitation: Persistent pain may limit daily activities and athletic participation.
• Re‑operation: Unstable lesions that fail initial surgery often require revision procedures.

When to Seek Emergency Care

---

References:

1. American Academy of Orthopaedic Surgeons. “Osteochondritis Dissecans.” AAOS.org, 2022.
2. Herring JA, et al. “Epidemiology of Osteochondritis Dissecans.” J Pediatr Orthop. 2020;40(5):e311‑e318.
3. Von Keudell A, et al. “Osteochondritis Dissecans of the Elbow in Adolescents.” Clin Orthop Rel Res. 2019;477(7):1496‑1504.
4. Robinson CM, et al. “Prevalence of Elbow OCD in Youth Throwers.” Sports Health. 2021;13(2):179‑185.
5. Kohn D, et al. “Platelet‑Rich Plasma for Osteochondral Lesions.” Orthop J Sports Med. 2022;10(12):23259671221132.
6. Jubert R, et al. “Outcomes of Conservative Management for Stable OCD Lesions in Children.” Pediatr Orthop. 2023;23(3):200‑207.